Capital Fund Management (“CFM”), the quantitative investment management firm, is pleased to announce the appointment of Laurent Laloux as Chief Product Officer and Board Director. In this newly-created role Dr. Laloux will manage product development with a particular focus on evolving CFM’s research and IT capabilities, to best support the firm’s growth and broader offering. The appointment follows the ongoing success of the Institutional Systematic (IS) program, CFM’s range of alternative beta products, which has raised over US$1.6bn since its launch in 2013. The IS program encompasses a number of strategies designed to deliver genuinely diversified returns at attractive fees within a framework of constant risk.

The Board of CFM commented: “We are delighted to welcome Laurent to the Board in what is the first such appointment in more than 10 years. Our continued growth and ambitions for scale necessitate careful management to ensure that, as our business evolves, we retain and build on the firm’s capabilities in a holistic fashion that reflects our increasingly varied investor base. Over his 20-year career at CFM, Laurent has built and managed some of our most successful strategies, making him ideally placed to play a prominent role in managing the firm’s evolution from a niche hedge fund business to a broader asset manager.”

Dr. Laloux said: “I join the Board at an exciting and important juncture for CFM. The firm has established itself as one of Europe’s leading hedge funds and I am proud to have witnessed and contributed to its success. The next chapter promises to be both exciting and challenging, as we use our collective capabilities and academic approach to broaden our offering in a way that captures the commercial opportunities we see and preserves the culture that our investors value.”